review Open AccessTop 1% cited
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Cancer Cell · 2014 · Vol. 25(3) · pp. 304–317
Patricia Müller✉(Medical Research Council)Karen H. Vousden
Cancer-related Molecular PathwaysEpigenetics and DNA MethylationCancer Research and TreatmentsMutantCancerCancer researchCancer cellBiologyComputational biologyGeneticsGene
MeSH terms
AnimalsHumansMutationNeoplasmsSignal TransductionGene Expression Regulation, NeoplasticTumor Suppressor Protein p53ApoptosisMice
Funding
- Cancer Research Society
- Wellcome Trust
- Cancer Research UK
- Royal Society
Citations
1,533
FWCI
62.94
field-weighted impact
References
183
Percentile
100%
vs. same field & year
Citations per year
Cited by
The p53 Pathway in Glioblastoma
Cancers · 2018 · 422 citations
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
Oncotarget · 2015 · 382 citations
p53 Family and Cellular Stress Responses in Cancer
Frontiers in Oncology · 2014 · 289 citations
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Cell Reports · 2019 · 758 citations
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Cell Death and Disease · 2022 · 411 citations
Small Nucleolar RNAs: Insight Into Their Function in Cancer
Frontiers in Oncology · 2019 · 288 citations
References
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
Oncogene · 2007 · 888 citations
p53 mutations in cancer
Nature Cell Biology · 2012 · 1,628 citations
Hallmarks of cancer: Interactions with the tumor stroma
Experimental Cell Research · 2010 · 1,137 citations
Integrins in cancer: biological implications and therapeutic opportunities
Nature reviews. Cancer · 2009 · 3,680 citations
Regulation of autophagy by cytoplasmic p53
Nature Cell Biology · 2008 · 1,101 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.